Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbonyl iron supplementation after blood donation in women aged 18-45 years
ACTRN12609000496213Phase 3Completed
- Sponsor
- Australian Red Cross
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Carbonyl iron with Placebo (2 arms). Primary endpoints: Change in total body iron and Iron deficiency anaemia based on venous haemoglobin and total body iron. Started Mar 2009; status: completed.
02
Drugs
Iron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12609000496213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000496213.